期刊文献+

通心络联合丁苯酞治疗脑小血管病所致认知功能障碍的临床效果 被引量:7

Clinical effect of Tongxinluo combined with butylphthalide in the treatment of cognitive dysfunction caused by cerebral small vessel disease
暂未订购
导出
摘要 :目的观察中医络病理论指导下的通心络联合丁苯酞治疗脑小血管病(CSVD)所致认知功能障碍的临床效果。方法纳入88例存在认知功能障碍的CSVD患者为研究对象,按照随机数字表法将其分为试验组(42例)和对照组(46例)。在内科常规治疗的基础上,对照组给予丁苯酞,试验组给予丁苯酞+通心络。比较两组患者的治疗效果。结果治疗后,两组MoCA评分均提高,且试验组高于对照组,差异有统计学意义(P<0.05);治疗后,两组ADL评分均提高,且试验组高于对照组,差异有统计学意义(P<0.05);试验组治疗总有效率为76.19%,显著高于对照组的52.17%(P<0.05)。结论通心络联合丁苯酞治疗CSVD所致认知功能障碍的效果优于单用丁苯酞,可显著改善患者的日常生活能力,提示中医络病理论在改善CSAD所致认知功能障碍方面具有一定优势。 Objective To observe the clinical effect of Tongxinluo under the theory of collateral disorders of traditional Chinese medicine combined with butylphthalide in the treatment of cognitive dysfunction caused by cerebral small vessel disease(CSVD).Methods Eighty-eight CSVD patients with cognitive dysfunction were included as the study objects.The patients were divided into experimental group(42 cases)and control group(46 cases)according to random number table method.On the basis of routine medical treatment,the control group was given butylphthalide,and the experimental group was given butylphthalide+Tongxinluo.The therapeutic effects of the two groups were compared.Results After treatment,the MoCA scores of both groups improved,and that in the experimental group was higher than the control group,the differences were statistically significant(P<0.05).After treatment,the ADL scores of both groups improved,and that in the experimental group was higher than the control group,the differences were statistically significant(P<0.05).The total effective rate of treatment in the experimental group was 76.19%,which was significantly higher than 52.17%in the control group(P<0.05).Conclusion Tongxinluo combined with butylphthalide in the treatment of cognitive dysfunction caused by CSVD has better effect than that of butylphthalide alone,it can significantly improve the patients'daily living ability.It may suggest that theory of collateral disorders of traditional Chinese medicine has certain advantages in improvement of cognitive dysfunction caused by CSAD.
作者 周辉 马菁菁 罗改莹 余华 ZHOU Hui;MA Qing-qing;LUO Gai-ying;YU Hua(Xi'an No.5 Hospital,Xi'an 710000;Shaanxi Traditional Chinese Medicine Hospital,Xi'an 710000,China)
出处 《临床医学研究与实践》 2019年第22期65-66,79,共3页 Clinical Research and Practice
关键词 脑小血管病 认知功能障碍 丁苯酞 通心络 cerebral small vessel disease cognitive dysfunction butylphthalide Tongxinluo
  • 相关文献

参考文献4

二级参考文献34

  • 1张进,蒋青青.dl-3-正丁基苯酞软胶囊治疗急性脑梗死[J].中国临床神经科学,2006,14(3):281-284. 被引量:12
  • 2焦东亮,倪秀石,高艳,赵杨,夏煜.丁苯酞对大鼠局灶性脑缺血再灌注损伤后caspase-3表达的影响[J].中国临床神经科学,2007,15(1):19-23. 被引量:54
  • 3中华神经科学会 中华神经外科学会.各类脑血管病诊断要点[J].中华神经科杂志,1996,6:379-379.
  • 4胡盾,张丽英,冯亦璞.丁基苯酞对局部脑缺血大鼠记忆障碍的影响[J].中国药理学与毒理学杂志,1997,11(1):14-16. 被引量:22
  • 5Lyden P,Brott T,Tilley B,et al.Improved reliability of the NIH Stroke Scale using video training.NINDS TPA Stroke Study Group[J].Stroke,1994,25:2220-2226.
  • 6Sulter G,Steen C,De Keyser J.Use of the Barthel index and modified Rankin scale in acute stroke trials[J].Stroke,1999,30:1538-1541.
  • 7Chang Q,Wang XL.Effects of chiral 3-n-butylphthalide on apoptosis induced by transient focal cerebral ischemia in rats[J].Acta Pharmacol Sin,2003,24:796-804.
  • 8Liu CL,Liao SJ,Zeng JS,et al.dl-3n-butylphthalide prevents stroke via improvement of cerebral microvessels in RHRSP[J].J Neurol Sci,2007,260:106-113.
  • 9Ladurner G,Kalvach P,Moessler H,et al.Neuroprotective treatment with cerebrolysin in patients with acute stroke:a randomised controlled trial[J].J Neural Transm,2005,112:415-428.
  • 10Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN international workshop. Neurology, 1993,43 : 250-260.

共引文献58

同被引文献116

引证文献7

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部